Tetraphase's Broad-Spectrum Antibiotic Candidate Makes A Good Showing At ICAAC
This article was originally published in The Pink Sheet Daily
Executive Summary
The Boston area start-up aims to offer a "franchise of antibiotics" based on its synthetic tetracycline platform.